Clinical Trials

GastrointestinalHead & Neck

12 enrolled

Head and Neck Neoplasms, Pancreatic Neoplasms

NCT07089940 2025-07-29

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

12 enrolled

Pancreatic Neoplasms

NCT03572283 2025-06-05

Bethanechol Prior to Pancreatic Surgery

17 enrolled

Adenocarcinoma, Pancreatic Neoplasms

NCT04665947 2025-05-28

First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer

30 enrolled

Pancreatic Neoplasms

NCT06577532 2025-05-21

Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors

56 enrolled

Pancreatic Neoplasms

NCT00902759 2025-05-02

Fatigue and Pancreas and Bile Duct Cancer Study

100 enrolled

Fatigue, Pancreatic Neoplasms

NCT02896907 2025-04-30

Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery

8 enrolled 9 charts

Pancreatic Neoplasms

NCT04048278 2025-03-03

Lidocaine Infusion in Pancreatic Cancer

46 enrolled

Pancreatic Neoplasms

NCT03153410 2025-01-09

Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas

11 enrolled 14 charts

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

NCT06619886 2024-10-01

TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor

Phase EARLY_PHASE1 Active not recruiting

9 enrolled

GastrointestinalThoracic

Adenocarcinoma of Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05482451 2024-08-21

Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer

10 enrolled

Pancreatic Neoplasms

NCT04067960 2024-08-14

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

CNSGastrointestinalGenitourinaryGynecologic

197 enrolled

Brain Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

NCT03492164 2024-06-12

In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer

6 enrolled

Phase EARLY_PHASE1 Active not recruiting

Pancreatic Neoplasms

NCT04862260 2024-05-22

Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

3 enrolled

Hyperlipoproteinemia Type II, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT06326736 2024-03-22

Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer

12 enrolled

Pancreatic Neoplasms

NCT03519308 2024-03-15

A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer

3 enrolled 13 charts

Pancreatic Neoplasms

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT06196658 2024-01-09

Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct Cancer

6 enrolled

Pancreatic Neoplasms

NCT04870034 2023-12-22

Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer

GastrointestinalThoracic

Adenocarcinoma of Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT06156267 2023-12-05

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

30 enrolled

Phase EARLY_PHASE1 Unknown

Pancreatic Neoplasms

NCT06054984 2023-10-13

GB3010-02

18 enrolled

Pancreatic Neoplasms

NCT02683824 2023-09-21

Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

21 enrolled

Phase EARLY_PHASE1 Unknown

Pancreatic Neoplasms

NCT05875753 2023-05-25

68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer

50 enrolled

Pancreatic Neoplasms

NCT05583201 2023-02-08

NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors

18 enrolled

Pancreatic Neoplasms, Stomach Neoplasms

NCT01371240 2022-06-16

Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity

Phase EARLY_PHASE1 Unknown

Pancreatic Neoplasms

NCT04966143 2021-07-19

Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer

30 enrolled

Pancreatic Neoplasms

NCT03536208 2021-03-25

Biological Effect of Warfarin on Pancreatic Cancer

Pancreatic Neoplasms

NCT03718650 2021-02-08

Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer

Pancreatic Neoplasms

NCT01715142 2020-09-04

NEOPAX-001

23 enrolled

Pancreatic Neoplasms

NCT03600623 2020-08-18

Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer

25 enrolled

Pancreatic Neoplasms

NCT02153450 2020-06-26

Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer

8 enrolled

Pancreatic Neoplasms

NCT00414570 2019-08-28

An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs

11 enrolled

Pancreatic Neoplasms

NCT03481920 2019-08-22

A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer

7 enrolled

Pancreatic Neoplasms

NCT01992705 2019-08-19

GCC 1324

8 enrolled

Pancreatic Neoplasms

NCT01276613 2019-05-02

Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas

18 enrolled

Pancreatic Neoplasms

NCT00364364 2019-01-18

Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer.

2 enrolled